Literature DB >> 8045148

Ischemic stroke: today and tomorrow.

R J Wityk1, B J Stern.   

Abstract

OBJECTIVE: To review selected aspects of the current treatment of acute ischemic stroke and provide an overview of basic neuroscience research in cerebral ischemia that may be applicable to future therapies. DATA SOURCES: Selected recent references dealing with current therapy of acute stroke and basic neuroscience developments in cerebrovascular disease from the past several years. STUDY SELECTION/DATA EXTRACTION: Whenever possible, recommendations concerning treatment were based on results of clinical trials; when such data were lacking, the authors present possible treatment approaches. DATA SYNTHESIS: Acute stroke is a heterogeneous process involving different etiologic mechanisms. Different types of stroke, however, may produce a similar cascade of physiologic and biochemical events leading to tissue damage. Calcium flux, glutamate excitotoxicity, platelet and leukocyte activation, free radical formation, and nitric oxide metabolism may be crucial focal points of future stroke therapy.
CONCLUSIONS: Recent clinical trials have given scientific basis for some of our treatment approaches to ischemic stroke. Future treatments for stroke will likely focus on factors which modulate biochemical events occurring as a final common pathway to all forms of cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8045148     DOI: 10.1097/00003246-199408000-00012

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

Review 1.  Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging.

Authors:  L P Mark; R W Prost; J L Ulmer; M M Smith; D L Daniels; J M Strottmann; W D Brown; L Hacein-Bey
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

Review 2.  Neuroprotection for ischaemic stroke: an unattainable goal?

Authors:  D S Liebeskind; S E Kasner
Journal:  CNS Drugs       Date:  2001       Impact factor: 6.497

3.  Genetic modification of glaucoma associated phenotypes between AKXD-28/Ty and DBA/2J mice.

Authors:  M G Anderson; R S Smith; O V Savinova; N L Hawes; B Chang; A Zabaleta; R Wilpan; J R Heckenlively; M Davisson; S W John
Journal:  BMC Genet       Date:  2001-01-15       Impact factor: 2.797

4.  Spinal Fluid Lactate Dehydrogenase Level Differentiates between Structural and Metabolic Etiologies of Altered Mental Status in Children.

Authors:  Nahid Khosroshahi; Parastoo Alizadeh; Mehdi Khosravi; Peyman Salamati; Kamyar Kamrani
Journal:  Iran J Child Neurol       Date:  2015
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.